functional dyspepsia
Conditions
Interventions
Conventional Western Medicine Monotherapy Group:NA
Xiangshao Granules Combined with Conventional Western Medicine Group:NA
Sponsors
The Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meeting the diagnostic criteria for functional dyspepsia; 2. Score >= 10 on the Generalized Anxiety Disorder Scale (GAD-7) or score >= 10 on the Patient Health Questionnaire-9 (PHQ-9); 3. Female, aged 18–75 years; 4. Voluntarily signing the informed consent form and being able to cooperate with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Reflux esophagitis (LA Grade B or above), active peptic ulcer, positive Helicobacter pylori test results, malignant tumors of the digestive tract, and other organic diseases that may cause dyspeptic symptoms; 2. Patients with severe diseases of the cardiovascular, hepatic, pulmonary, renal, or hematological systems, or malignant tumors; Mental illnesses: schizophrenia, bipolar affective disorder, etc. 3. Mental illnesses: schizophrenia, bipolar affective disorder, etc. 4. Pregnant or lactating women; 5. Patients allergic to the components of Xiangshao Granules (Cyperi Rhizoma, Paeoniae Radix Alba, etc.); 6. Patients who have participated in other clinical trials within the past 3 months; 7. Other circumstances deemed unsuitable for enrollment by the researcher;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction rate of the main symptom score of functional dyspepsia;Scores of Scales Including GAD-7, PHQ-9, and PHQ-15;Incidence Rate of Adverse Events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Score of the Functional Gastrointestinal Disorder Quality of Life Scale (FDDQL);Evaluation of therapeutic efficacy for other symptoms of functional dyspepsia; | — |
Countries
China
Contacts
Public ContactSujuan Fei
The Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed